copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
02_ToR_EPO WG_Jan 2023 - wada-ama. org The WADA EPO Working Group (EPO WG) is a specific Working Group1 created by the WADA Science Medicine Department at the request of the WADA Laboratory Expert Advisory Group (Lab EAG) These Terms of Reference are approved by the WADA Director General, following consultation with the Senior Associate Director of Science Medicine (Laboratories)
Laboratories - World Anti Doping Agency Laboratories that analyze doping control samples for sport under the World Anti-Doping Code (Code) must achieve and maintain accreditation from the World Anti-Doping Agency (WADA) The International Standard for Laboratories (ISL) and its related Technical Documents specify the criteria that must be met for accreditation and re-accreditation, as well as standards that must be met for the
TD2024EPO - World Anti Doping Agency This Technical Document (TD) has been established to harmonize the detection and reporting of erythropoietin (EPO) and other EPO-receptor agonists (ERAs) by Laboratories when analyzed using PolyAcrylamide Gel-Electrophoretic (PAGE) Analytical Methods Whenever other techniques are available (e g , LC-MS), reference to the applicable TD (s) is also made A Summary of Modifications can be found
The Prohibited List | World Anti Doping Agency Please take note that the search results displayed here are categorized by Substance or Method To ensure you find the specific information you need, we strongly encourage you to open the relevant category and review the complete list of Prohibited Substances and Methods A category may be displayed in the search results based on the similarities in the names of some Substances and Methods If
WADA publishes data supporting a deterrent effect of testing The World Anti-Doping Agency (WADA) is pleased to share positive insights from a study it recently published examining the impact of anti-doping testing on rates of Adverse Analytical Findings (AAFs)